Recognized for its biotech-first focus, innovation in clinical trial delivery, and best-in-class client experience, Novotech ...

The GCAptAIN study did not meet its primary endpoint of sustained remission at Week 52 in adults with newly diagnosed or relapsing GCA1 ...

Focused ultrasound targeting the amygdala safely reduced emotional brain reactivity and improved symptoms of depression, anxiety, and trauma disorders, suggesting it may be a promising new treatment ...

The analysis reveals a strong dominance of AI applications in oncology, comprising 72.8% of all included studies. This skew ...

July is Sarcoma Awareness Month. Sarcoma is a rare type of cancer in connective tissues like bone, muscle, fat or cartilage.

Arcturus has made progress in cost-cutting and focusing on CF and OTC deficiency. Click here to find out the factors that ...

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Lynozyfic™ (linvoseltamab-gcpt) to treat adult ...

Atai Life Sciences is making incremental progress towards opening door for a first psychedelic treatment for depression. Read ...

For the past six years, it has ranked among the world’s top 20 medical schools. Read more at straitstimes.com. Read more at ...

A team of researchers from the San Raffaele-Telethon Institute for Gene Therapy (SR-TIGET, Milan), led by Nadia Coltella and ...

Sanofi has agreed to invest up to $25m in Adagene, which will enable the latter to fund its research and development (R&D) ...

Kate, 43, looked stunning in smart attire as she visited the RHS's Wellbeing Garden at Colchester Hospital today.